Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 65,000 | |
| Jul 27, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $6.10 | 193,204 | |
| Jul 27, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $15.05 | 163,204 | |
| Jul 27, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 30,000 | |
| Jul 16, 2020 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $5.16 | 225,169 | |
| Jul 16, 2020 | Chief Legal Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $15.26 | 195,169 | |
| Jul 16, 2020 | Chief Legal Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 95,000 | |
| Jun 29, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $5.13 | 193,204 | |
| Jun 29, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $15.51 | 163,204 | |
| Jun 29, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 40,621 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.